Plasma IL-6 and C-reactive protein (CRP) have been shown in smaller studies to be prognostic biomarkers for OS in patients undergoing surgery for MBD [16], but the prognostic value of plasma YKL-40 in these patients is unknown. The gene discussed is CHI3L1; the disease is Marchiafava-Bignami disease.